765 related articles for article (PubMed ID: 22902483)
1. Treatment of breast cancer during pregnancy: an observational study.
Loibl S; Han SN; von Minckwitz G; Bontenbal M; Ring A; Giermek J; Fehm T; Van Calsteren K; Linn SC; Schlehe B; Gziri MM; Westenend PJ; Müller V; Heyns L; Rack B; Van Calster B; Harbeck N; Lenhard M; Halaska MJ; Kaufmann M; Nekljudova V; Amant F
Lancet Oncol; 2012 Sep; 13(9):887-96. PubMed ID: 22902483
[TBL] [Abstract][Full Text] [Related]
2. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry.
Cardonick E; Usmani A; Ghaffar S
Am J Clin Oncol; 2010 Jun; 33(3):221-8. PubMed ID: 19745695
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer during pregnancy: maternal and fetal outcomes.
Cardonick E; Dougherty R; Grana G; Gilmandyar D; Ghaffar S; Usmani A
Cancer J; 2010; 16(1):76-82. PubMed ID: 20164696
[TBL] [Abstract][Full Text] [Related]
4. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.
Amant F; Van Calsteren K; Halaska MJ; Gziri MM; Hui W; Lagae L; Willemsen MA; Kapusta L; Van Calster B; Wouters H; Heyns L; Han SN; Tomek V; Mertens L; Ottevanger PB
Lancet Oncol; 2012 Mar; 13(3):256-64. PubMed ID: 22326925
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero.
Hahn KM; Johnson PH; Gordon N; Kuerer H; Middleton L; Ramirez M; Yang W; Perkins G; Hortobagyi GN; Theriault RL
Cancer; 2006 Sep; 107(6):1219-26. PubMed ID: 16894524
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary approach to breast cancer diagnosed during pregnancy: maternal and neonatal outcomes.
Córdoba O; Llurba E; Saura C; Rubio I; Ferrer Q; Cortés J; Xercavins J
Breast; 2013 Aug; 22(4):515-9. PubMed ID: 23116970
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Mackey JR; Martin M; Pienkowski T; Rolski J; Guastalla JP; Sami A; Glaspy J; Juhos E; Wardley A; Fornander T; Hainsworth J; Coleman R; Modiano MR; Vinholes J; Pinter T; Rodríguez-Lescure A; Colwell B; Whitlock P; Provencher L; Laing K; Walde D; Price C; Hugh JC; Childs BH; Bassi K; Lindsay MA; Wilson V; Rupin M; Houé V; Vogel C;
Lancet Oncol; 2013 Jan; 14(1):72-80. PubMed ID: 23246022
[TBL] [Abstract][Full Text] [Related]
9. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients.
de Haan J; Verheecke M; Van Calsteren K; Van Calster B; Shmakov RG; Mhallem Gziri M; Halaska MJ; Fruscio R; Lok CAR; Boere IA; Zola P; Ottevanger PB; de Groot CJM; Peccatori FA; Dahl Steffensen K; Cardonick EH; Polushkina E; Rob L; Ceppi L; Sukhikh GT; Han SN; Amant F;
Lancet Oncol; 2018 Mar; 19(3):337-346. PubMed ID: 29395867
[TBL] [Abstract][Full Text] [Related]
10. Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy.
Abdel-Hady el-S; Hemida RA; Gamal A; El-Zafarany M; Toson E; El-Bayoumi MA
Arch Gynecol Obstet; 2012 Aug; 286(2):283-6. PubMed ID: 22410958
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for breast carcinoma during pregnancy: A French national survey.
Giacalone PL; Laffargue F; Bénos P
Cancer; 1999 Dec; 86(11):2266-72. PubMed ID: 10590367
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
[TBL] [Abstract][Full Text] [Related]
13. Assisted reproductive technology surveillance -- United States, 2010.
Sunderam S; Kissin DM; Crawford S; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
MMWR Surveill Summ; 2013 Dec; 62(9):1-24. PubMed ID: 24304902
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study.
Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T
BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157
[TBL] [Abstract][Full Text] [Related]
15. Birth weight in relation to morbidity and mortality among newborn infants.
McIntire DD; Bloom SL; Casey BM; Leveno KJ
N Engl J Med; 1999 Apr; 340(16):1234-8. PubMed ID: 10210706
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
[TBL] [Abstract][Full Text] [Related]
17. Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy.
Joh JE; Esposito NN; Kiluk JV; Laronga C; Khakpour N; Soliman H; Catherine Lee M
Breast J; 2012; 18(6):569-74. PubMed ID: 23034096
[TBL] [Abstract][Full Text] [Related]
18. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
19. Duration of anti-HER2 blockage therapy may improve survival in HER2 positive metastatic breast carcinoma patients.
Arslan UY; Turker I; Aksoy S; Oksuzoglu B; Helvaci K; Yildirim Ozdemir N; Uyeturk U; Uysal Sonmez O; Budakoglu B; Zengin N
J BUON; 2013; 18(3):585-93. PubMed ID: 24065468
[TBL] [Abstract][Full Text] [Related]
20. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]